Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025
Compare Balance Sheet Results of Ganga Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.91
24.05
-18.14
-75.43%
Share Warrants & Outstandings
Total Reserve
2.40
14.45
-12.05
-83.39%
Shareholder's Funds
8.31
38.49
-30.18
-78.41%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.10
8.89
-8.79
-98.88%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.10
8.89
-8.79
-98.88%
Deferred Tax Assets / Liabilities
0.00
-0.00
0.00
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.10
8.89
-8.79
-98.88%
Current Liabilities
Trade Payables
0.12
75.72
-75.60
-99.84%
Other Current Liabilities
0.13
0.94
-0.81
-86.17%
Short Term Borrowings
0.99
8.33
-7.34
-88.12%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
1.24
85.00
-83.76
-98.54%
Total Liabilities
9.65
132.38
-122.73
-92.71%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.50
0.13
1.37
1,053.85%
Less: Accumulated Depreciation
0.86
0.08
0.78
975.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.65
0.05
0.60
1,200.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
1.44
0.00
1.44
0.00%
Total Non-Current Assets
2.08
0.05
2.03
4,060.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1.17
27.43
-26.26
-95.73%
Sundry Debtors
0.94
46.28
-45.34
-97.97%
Cash and Bank
0.06
0.43
-0.37
-86.05%
Other Current Assets
2.48
1.14
1.34
117.54%
Short Term Loans and Advances
2.93
57.05
-54.12
-94.86%
Total Current Assets
7.56
132.33
-124.77
-94.29%
Net Current Assets (Including Current Investments)
6.33
47.33
-41.00
-86.63%
Total Current Assets Excluding Current Investments
7.56
132.33
-124.77
-94.29%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.65
132.38
-122.73
-92.71%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.09
17.22
-16.13
-93.67%
Book Value per share (adjusted)
14.06
16.01
-1.95
-12.18%
Annual - Borrowings
Borrowings 1.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.65 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Current Assets
Current Assets 7.56 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025